Matt Humphrey
Partner @ Quiet Capital
San Francisco, United States
Matt Humphrey is a Partner at Quiet Capital. He was the Co-Founder and CEO of LendingHome Corporation before that. Matt graduated from Carnegie Mellon University - Tepper School of Business.
- Total investments:
- 28
- Last investment:
- Lead investor:
- 14%
Last updated:
For AI agents: llms.txt
Industries Matt Humphrey invests in
Stages Matt Humphrey invests in
Countries Matt Humphrey invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 10 (36%)
- Artificial Intelligence 6 (21%)
- Financial Services 5 (18%)
- FinTech 4 (14%)
- Apps 3 (11%)
Stage
- Seed 20 (71%)
- Series A 4 (14%)
- Pre-Seed 1 (4%)
- Series B 1 (4%)
- Series C 1 (4%)
Country
- United States 23 (82%)
- Canada 1 (4%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Assort Health is building healthcare that remembers.From call center automation and form intake to referrals, document processing, outreach, and payments, we manage the entire patient journey for providers. Our platform is the most widely used AI agents platform for the patient journey, built on 180 million specialty patient interactions and amodel that handles the complexity general-purpose AI can’t.Healthcare organizations see a 5% lift in appointment volume, a 115% increase in labor capacity, and a 4.3 out of 5 patient satisfaction score.With over $222M raised from Menlo Ventures, Lightspeed, First Round Capital, Apolo Ohno, and Joe Montana, Assort is becoming the standard for how providers use AI to transform the patient journey.Learn more at assorthealth.com | $120M / Series C / Jun 24, 2026 | ||
| Assort Health is building healthcare that remembers.From call center automation and form intake to referrals, document processing, outreach, and payments, we manage the entire patient journey for providers. Our platform is the most widely used AI agents platform for the patient journey, built on 180 million specialty patient interactions and amodel that handles the complexity general-purpose AI can’t.Healthcare organizations see a 5% lift in appointment volume, a 115% increase in labor capacity, and a 4.3 out of 5 patient satisfaction score.With over $222M raised from Menlo Ventures, Lightspeed, First Round Capital, Apolo Ohno, and Joe Montana, Assort is becoming the standard for how providers use AI to transform the patient journey.Learn more at assorthealth.com | $76M / Series B / Oct 02, 2025 | ||
| Assort Health is building healthcare that remembers.From call center automation and form intake to referrals, document processing, outreach, and payments, we manage the entire patient journey for providers. Our platform is the most widely used AI agents platform for the patient journey, built on 180 million specialty patient interactions and amodel that handles the complexity general-purpose AI can’t.Healthcare organizations see a 5% lift in appointment volume, a 115% increase in labor capacity, and a 4.3 out of 5 patient satisfaction score.With over $222M raised from Menlo Ventures, Lightspeed, First Round Capital, Apolo Ohno, and Joe Montana, Assort is becoming the standard for how providers use AI to transform the patient journey.Learn more at assorthealth.com | $22M / Series A / Apr 16, 2025 | ||
| Assort Health is building healthcare that remembers.From call center automation and form intake to referrals, document processing, outreach, and payments, we manage the entire patient journey for providers. Our platform is the most widely used AI agents platform for the patient journey, built on 180 million specialty patient interactions and amodel that handles the complexity general-purpose AI can’t.Healthcare organizations see a 5% lift in appointment volume, a 115% increase in labor capacity, and a 4.3 out of 5 patient satisfaction score.With over $222M raised from Menlo Ventures, Lightspeed, First Round Capital, Apolo Ohno, and Joe Montana, Assort is becoming the standard for how providers use AI to transform the patient journey.Learn more at assorthealth.com | $3.5M / Seed / Mar 14, 2024 | ||
| Taalas is creating a platform for quickly turning any AI model into custom silicon. | $36.8M / Series A / Mar 05, 2024 | ||
| Enki builds AI products for the workforce development and upskilling industry. Offers a dynamic and adaptive educational experience that caters to the evolving needs of professionals seeking to enhance their technical skills. | $1.5M / Seed / Jun 17, 2022 | ||
| Our mission is to use technology and design to level the playing field for small businesses and the common person in a world where typically on the wealthiest people and large corporations can afford expensive counsel. | $2.3M / Pre-Seed / Mar 31, 2021 | ||
| Einsite is building AI to track and boost productivity in the Mining and Construction Industries | $1.7M / Seed / Feb 28, 2020 | ||
| Etleap is an ETL solution for creating perfect data pipelines from day one. Unlike other enterprise solutions, Etleap doesn’t require extensive engineering work to set up, maintain, and scale. Etleap builds tools to make data analytics teams more productive. It automates most ETL setup and maintenance work and simplifies the rest into 10-minutetasks that analysts can own. | $1.5M / Seed / Apr 24, 2018 | ||
| Mirror uses a single selfie to instantly create hundreds of emoji that look like you and your friends. You can then use these in all messengers. | $3.5M / Seed / Dec 13, 2017 | ||
| See all 28 investments → | |||
Co-Investors
About Quiet Capital
Quiet Capital is a technology investment firm.
Quiet Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
David Greenbaum
Partner
|
|||
Ben Mahdavi
Managing Partner
|
|||
|
Chris Capozzi
Partner & Chief Financial Officer
|
|||
Daniel Gruneberg
Partner
|
|||
Jeff Silverstein
Venture Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Matt Humphrey invest in?
Matt Humphrey invests primarily in Software, Artificial Intelligence and Financial Services startups, most often at Seed and Series A stage. Most of the 28 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Matt Humphrey?
Public channels for Matt Humphrey include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Matt Humphrey last invest?
The most recent investment recorded for Matt Humphrey closed in Jun 2026. Shizune tracks 28 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
